ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 175493 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 175493; 2) Community: the network communities that were significantly associated with the response to NSC 175493; 3) Molecule: the relationships between components within communities and NSC 175493; 4) MDR: the compounds that were significantly associated with the NSC 175493.

NSC Compound Enrichment Correlation
NSC 705941 Null 0.0137891122538509 0.37354834
NSC 718688 Null 0.0137891122538509 0.27887544
NSC 724781 (1S,4R,5R,8R,12R,13S)-9-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl -10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10.3.1. 04,13.08,13]hexadec-9-en-9-yl]methoxy}-2-butenyl)oxy]methyl} -1,5-dimethyl-10 0.0137891122538509 0.19231901
NSC 736163 pyrazoline derivative 0.0137891122538509 0.30519694
NSC 756188 GSK718429A 0.0137891122538509 0.38309397
NSC 760476 5,6,7,8-tetrafluoronaphtho[2,3-c][1,2,5]thiadiazole-4,9-dione 0.0137891122538509 0.43321565
NSC 7821 [6-(Dimethylamino)-3H-phenoxazin-3-ylidene]dimethylammonium chloride 0.0137891122538509 0.064386268
NSC 98904 Thiazolo[3,2-f]phenanthridinium, 3-phenyl- perchlorate 0.0137891122538509 0.13533531
NSC 114346 Null 0.013789112253851 0.43842084
NSC 23416 Null 0.0171490505199911 0.23793496
Total:82  Current:33    [First] [Prev] [Next] [Last]